Maryland National Guard Specialist James Truong (left) administers a Moderna coronavirus vaccine at CASA Maryland’s Wheaton Reception Center on May 21, 2021 in Wheaton, Maryland.
Chip Somodevilla | Getty Images
At least 1.5 million Americans received a booster of the Covid-19 vaccine from Moderna or Johnson & Johnson in the first five days after US regulators authorized the additional doses, a House official said on Wednesday. White.
“Our recall program is off to a very good start,” Jeff Zients, the White House coronavirus response coordinator, told reporters at a virtual press conference. He said the administration was working with states, pharmacies and other entities to quickly provide reminders to tens of millions of eligible Americans.
The Centers for Disease Control and Prevention on Thursday approved booster shots of Moderna and J&J’s Covid vaccines for millions of Americans.
The CDC has cleared the Moderna booster for administration to the elderly and at-risk adults six months after completing their first round of shots, bringing it in line with the Pfizer and BioNTech recall distribution plan. He also authorized the recall of J&J for adults who received the initial blow at least two months ago.
Zients said on Wednesday that at least 15 million Americans had received an additional dose of any approved Covid vaccine since health officials in August authorized third injections of Pfizer or Moderna vaccines for people with compromised immune systems. weakened.
While the Biden administration is still working to persuade hesitant adults to get their first Covid vaccine, it is also preparing to distribute doses to younger age groups, he said.
U.S. health officials are expected to approve a smaller dose of Pfizer’s Covid vaccine for children aged 5 to 11 as early as next week.
States have placed their first orders for pediatric doses, Zients said on Wednesday, and millions of doses will be distributed by the U.S. government following approval by federal regulators.
About 28 million children would become eligible for Pfizer’s vaccine, pending clearance from the Food and Drug Administration and CDC, he said.